1006469-47-1 Usage
Uses
Used in Water Treatment:
HEPCA is utilized as a chelating agent in water treatment processes to bind with metal ions, thereby facilitating their removal or recovery from water systems. This is crucial for purifying water and preventing the environmental impact of heavy metal contamination.
Used in Metal Extraction:
In the field of metallurgy, HEPCA serves as an effective chelating agent for the extraction of metals from ores or other sources. Its ability to form stable complexes with metal ions aids in the separation and concentration of these metals, enhancing the efficiency of extraction processes.
Used in Catalysis:
HEPCA is employed as a chelating agent in catalytic processes, where it can improve the selectivity and activity of catalysts by stabilizing metal ions or by preventing their aggregation.
Used in Analytical Chemistry:
HEPCA is used as a reagent in analytical chemistry for the separation and determination of metal ions in complex mixtures. Its chelating nature allows for the selective binding of metal ions, which can be instrumental in analytical techniques such as chromatography or spectroscopy.
Used in Environmental Applications:
HEPCA's chelating properties are harnessed in environmental applications to mitigate the effects of heavy metal pollution. It can be used to treat industrial effluents or to remediate contaminated sites by binding and sequestering metal ions, thus reducing their bioavailability and toxicity.
Check Digit Verification of cas no
The CAS Registry Mumber 1006469-47-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,6,4,6 and 9 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1006469-47:
(9*1)+(8*0)+(7*0)+(6*6)+(5*4)+(4*6)+(3*9)+(2*4)+(1*7)=131
131 % 10 = 1
So 1006469-47-1 is a valid CAS Registry Number.
1006469-47-1Relevant articles and documents
DIHYDROBENZOFURAN AND INDEN ANALOGS AS CARDIAC SARCOMERE INHIBITORS
-
Paragraph 0347, (2019/08/08)
Provided are compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A, Z, B, R1, R2, R3, G1, G2, and G3 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof Also provided are methods of using a compound of Formula (I), or a pharmaceutically acceptable salt, thereof for use in methods of treatment heart diseases through cardiac sarcomere inhibtion.
